Decreased mRNA expression of G-CSF receptor in cord blood neutrophils of term newborns. Regulation of expression by G-CSF and TNF-α

Biology of the Neonate

Volumn 77, Issue 3, 2000, Pages 168-173

  Gessler, Peter ^a,b   Neu, Stefan ^a   Brockmann, Yvonne ^a   Speer, Christian P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

G CSF receptor; Neutrophils; Receptor down regulation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL SURFACE; CONTROLLED STUDY; GRANULOPOIESIS; HOST RESISTANCE; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; NEUTROPHIL; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; UMBILICAL CORD BLOOD;

EID: 0034103959     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014212     Document Type: Article

References (37)

1. Gerdes JS: Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol 1991;18:361-381.
2. Perez EM, Weisman LE: Novel approaches to the prevention and therapy of neonatal bacterial sepsis. Clin Perinatol 1997;24:213-229.
3. Hill HR: Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate. Pediatr Res 1987;22:375-382.
4. Cairo MS: Therapeutic implications of dysregulated colony-stimulating factor expression in neonates. Blood 1993;82:2269-2272.
5. Christensen RD: Neutrophil kinetics in the fetus and neonate. Am J Pediatr Hematol Oncol 1989;11:215-223.
6. Welte K, Gabrilove J, Bronchud MH, Platzer E. Morstyn G: Filgrastim (r-metHuG-CSF): The first 10 years. Blood 1996;88:1907-1929.
7. Anderlini P, Przepiorka D, Champlin R, Körbling M: Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996;88:2819-2825.
8. Avalos BR: Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996;88:761-777.
9. Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, Weisbart RH, Williams RE, Golde DW, DiPersio JF: Human granulocyte colony-stimulating factor: Biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood 1990;75:851-857.
10. Budel LM, Touw IP, Delwel R, Löwenberg B: Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia. Blood 1989;74:2668-2673.
11. Steinman RA, Tweardy DJ: Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells. Blood 1994;83:119-127.
12. Khwaja A, Carver J, Jones HM, Paterson D, Linch DC: Expression and dynamic modulation of the human granulocyte colony-stimulating factor receptor in immature and differentiated myeloid cells. Br J Haematol 1993;85: 254-259.
13. Gessler P, Kirchmann N, Kientsch-Engel R, Haas N, Lasch P, Kachel W: Serum concentrations of granulocyte-colony stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections. Blood 1993;82:3177-3182.
14. Ishiguro A, Inoue K, Nakahata T, Nishihira H, Kojima S, Ueda K, Suzuki Y, Shimbo T: Reference intervals for serum granulocyte colony-stimulating factor levels in children. J Pediatr 1996;128:208-212.
15. Kennon C, Overturf G, Bessman S, Sierra E, Smith KJ, Brann B: Granulocyte colony-stimulating factor as a marker for bacterial infection in neonates. J Pediatr 1996;128:765-769.
16. Chirico G, Ciardelli L, Cecchi P, De Amici M, Gasparoni A, Rondini G: Serum concentration of granulocyte colony stimulating factor in term and preterm infants. Eur J Pediatr 1997; 156:269-271.
17. Gessler P, Neu S, Nebe T, Speer CP: Granulocytc colony-stimulating factor receptor expression on neutrophils of term and preterm neonates with and without signs of infection. Eur J Pediatr 1999;158:497-500.
18. Gerber CE, Kuci S, Zipfel M, Niethammer D, Bruchelt G: Phagocytic activity and oxidative burst of granulocytes in persons with myeloperoxidase deficiency. Eur J Clin Chem Clin Biochem 1996;34:901-908.
19. Beck J, Handgretinger R, Dopfer R, Klingebiel T, Niethammer D, Gekeler V: Expression of MDR1, MRP, topoisomerase II/, and cyclin A in primary or relapsed states of acute lymphoblastic leukemias. Br J Haematol 1995;89:356-363.
20. Sullivan GW, Carper HT, Mandell GL: The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. Blood 1993; 81:1863-1870.
21. Elbim C, Chollet-Martin S, Bailly S, Hakim J, Gougerot-Pocidalo MA: Priming of polymorphonuclear neutrophils by tumor necrosis factor alpha in whole blood: Identification of two polymorphonuclear neutrophil subpopulations in response to formyl-peptides. Blood 1993;82: 633-640.
22. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012-2020.
23. Shinjo K, Takeshita A, Ohnishi K, Ohno R: Expression of granulocyte colony-stimulating factor receptor increases with differentiation in mycloid cells by a newly-devised quantitative flow-cytometric assay. Br J Haematol 1995;91: 783-794.
24. Griffin JD, Linch D, Sabbath P, Larcom P, Schlossman SF: A monoclonal antibody reactive with normal and leukemic myeloid progenitor cells. Leuk Res 1984;8:521-525.
25. Scott EW, Simon MC, Anastasi J, Singh H: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994;265:1573-1577.
26. Sonoda Y, Yang Y-C, Wong GG, Clark SC, Ogawa M: Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: Interleukin 3 and granulocyte/ macrophage colony stimulating factor are specific for early developmental stages. Proc Natl Acad Sci USA 1988;85:4360-4364.
27. Cairo MS, Suen Y, Knoppel E, Ven C, Nguyen A, Sender L: Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared with adults. Pediatr Res 1991;30:362-367.
28. Elbaz O, Budel LM, Hoogerbrugge H. Touw IP, Delwel R, Mahmoud LA, Lowenberg B: Tumor necrosis factor downregulates granulocyte colony-stimulating factor receptor expression on human myeloid leukemia cells and granulocytes. J Clin Invest 1991;87:838-841.
29. Tkatch LS, Rubin KA, Ziegler SF, Tweardy DJ: Modulation of human G-CSF receptor mRNA and protein in normal and leukemic cells by G-CSF and retinoic acid. J Leuk Biol 1995;57:964-969.
30. Williams G, Smith CA, Spooncer E, Dexter TM, Taylor DR: Haematopoietic colony stimulating factors promote cell survival by supporting apoptosis. Nature 1990;343:76-79.
31. Cairo MS: Review of G-CSF and GM-CSF effects on neonatal neutrophil kinetics. Am J Pediatr Hematol Oncol 1989;11:238-245.
32. Metcalf D: Control of granulocytes and macrophages. Molecular, cellular, and clinical aspects. Science 1991;254:529-532.
33. Gillan E, Christensen R, Suen Y, Ellis R, van de Ven C, Cairo MS: A randomized, placebo-controlled trial of recombinant human granulocyte-colony stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and hone marrow neutrophilia. Blood 1994;84:1427-1433.
34. Rosenthal J, Healey T, Ellis R, Gillan E, Cairo MS: A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life. J Pediatr 1996;128:135-137.
35. Barak Y, Leibovitz E, Mogilner B, Juster-Reicher A, Amitay M, Ballin A, Koren A, Goebel M: The in vivo effect of recombinant human granulocyte-colony stimulating factor in neutropenic neonates with sepsis. Eur J Pediatr 1997;156:643-646.
36. Schibler KR, Osborne KA, Leung LY, Le TV, Baker SI, Thompson DD: A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics 1998;102:6-13.
37. Kocherlakota P, La Gamma EF: Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia. Pediatrics 1998;102: 1107-1111.